全文获取类型
收费全文 | 56310篇 |
免费 | 4685篇 |
国内免费 | 2173篇 |
专业分类
耳鼻咽喉 | 432篇 |
儿科学 | 855篇 |
妇产科学 | 687篇 |
基础医学 | 7290篇 |
口腔科学 | 3239篇 |
临床医学 | 6011篇 |
内科学 | 9128篇 |
皮肤病学 | 1082篇 |
神经病学 | 2781篇 |
特种医学 | 1883篇 |
外国民族医学 | 13篇 |
外科学 | 6782篇 |
综合类 | 6501篇 |
现状与发展 | 22篇 |
预防医学 | 1430篇 |
眼科学 | 783篇 |
药学 | 7537篇 |
16篇 | |
中国医学 | 1576篇 |
肿瘤学 | 5120篇 |
出版年
2024年 | 52篇 |
2023年 | 1023篇 |
2022年 | 1141篇 |
2021年 | 2257篇 |
2020年 | 2143篇 |
2019年 | 2034篇 |
2018年 | 2081篇 |
2017年 | 1970篇 |
2016年 | 1885篇 |
2015年 | 2089篇 |
2014年 | 3586篇 |
2013年 | 5344篇 |
2012年 | 3033篇 |
2011年 | 3576篇 |
2010年 | 2687篇 |
2009年 | 2780篇 |
2008年 | 2916篇 |
2007年 | 2811篇 |
2006年 | 2558篇 |
2005年 | 2345篇 |
2004年 | 2015篇 |
2003年 | 1729篇 |
2002年 | 1320篇 |
2001年 | 1169篇 |
2000年 | 906篇 |
1999年 | 839篇 |
1998年 | 669篇 |
1997年 | 658篇 |
1996年 | 492篇 |
1995年 | 525篇 |
1994年 | 443篇 |
1993年 | 366篇 |
1992年 | 361篇 |
1991年 | 347篇 |
1990年 | 328篇 |
1989年 | 276篇 |
1988年 | 258篇 |
1987年 | 206篇 |
1986年 | 188篇 |
1985年 | 273篇 |
1984年 | 217篇 |
1983年 | 159篇 |
1982年 | 185篇 |
1981年 | 195篇 |
1980年 | 166篇 |
1979年 | 112篇 |
1978年 | 99篇 |
1977年 | 72篇 |
1976年 | 92篇 |
1975年 | 40篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
目的 分析10-MDP-钙盐形成对牙本质粘接成绩的影响。方法 采用酸蚀冲洗粘接模式,根据牙本质表面的处理方式和选择粘接剂的不同将牙齿随机分为以下4组(n=5)进行处理,制作牙本质/树脂粘接试件:①对照组,直接使用全酸蚀粘接剂Single bond 2(SB2)处理后粘接;②10-MDP组,使用SB2处理进行粘接前,牙本质表面以含有磷酸酯单体10-MDP的自配底涂剂预处理;③CHX组,使用SB2处理进行粘接前,先以氯己定(CHX)预处理牙本质表面;④SBU组,使用包含10-MDP的通用型粘接剂Single bond universal(SBU)处理后进行粘接。通过微拉伸测试(μTBS)测试粘接强度,以X射线衍射(XRD)、原位酶谱测试表征自配10-MDP底涂剂和两种牙本质粘接剂处理的牙本质表面,分析10-MDP-钙盐形成对牙本质粘接成绩的影响。结果 微拉伸结果显示,不同处理方式的粘接试件在24 h水储后没有表现出明显的统计学差异(P>0.1);经过6个月的水储后,与10-MDP组和SBU组相比,对照组的微拉伸强度显著降低(P<0.05),而CHX组的微拉伸强度没有明显变化(P>0.05)。XRD结果显示,在10-MDP组和SBU组均检测到10-MDP-钙盐形成的特征性峰,表明有10-MDP-钙盐的形成。原位酶谱结果显示,10-MDP组与SBU组之间混合层荧光强度没有明显区别,但均明显高于对照组,CHX组荧光强度低于10-MDP组与SBU组。结论 10-MDP-钙盐的形成能够保护暴露的胶原纤维不接触到MMPs而免于水解,从而增强牙本质/树脂的粘接成绩。 相似文献
5.
Her-Shyong Shiah Nai-Jung Chiang Chia-Chi Lin Chia-Jui Yen Hui-Jen Tsai Shang-Yin Wu Wu-Chou Su Kwang-Yu Chang Ching-Chiung Wang Jang-Yang Chang Li-Tzong Chen 《The oncologist》2021,26(4):e567-e579
Lessons Learned
- SCB01A is a novel microtubule inhibitor with vascular disrupting activity.
- This first‐in‐human study demonstrated SCB01A safety, pharmacokinetics, and preliminary antitumor activity.
- SCB01A is safe and well tolerated in patients with advanced solid malignancies with manageable neurotoxicity.
6.
7.
8.
Major depressive disorder and other neuropsychiatric disorders are often managed with long-term use of antidepressant medication. Fluoxetine, an SSRI antidepressant, is widely used as a first-line treatment for neuropsychiatric disorders. However, fluoxetine has also been shown to increase the risk of metabolic diseases such as non-alcoholic fatty liver disease. Fluoxetine has been shown to increase hepatic lipid accumulation in vivo and in vitro. In addition, fluoxetine has been shown to alter the production of prostaglandins which have also been implicated in the development of non-alcoholic fatty liver disease. The goal of this study was to assess the effect of fluoxetine exposure on the prostaglandin biosynthetic pathway and lipid accumulation in a hepatic cell line (H4-II-E-C3 cells). Fluoxetine treatment increased mRNA expression of prostaglandin biosynthetic enzymes (Ptgs1, Ptgs2, and Ptgds), PPAR gamma (Pparg), and PPAR gamma downstream targets involved in fatty acid uptake (Cd36, Fatp2, and Fatp5) as well as production of 15-deoxy-Δ12,14PGJ2 a PPAR gamma ligand. The effects of fluoxetine to induce lipid accumulation were attenuated with a PTGS1 specific inhibitor (SC-560), whereas inhibition of PTGS2 had no effect. Moreover, SC-560 attenuated 15-deoxy-Δ12,14PGJ2 production and expression of PPAR gamma downstream target genes. Taken together these results suggest that fluoxetine-induced lipid abnormalities appear to be mediated via PTGS1 and its downstream product 15d-PGJ2 and suggest a novel therapeutic target to prevent some of the adverse effects of fluoxetine treatment. 相似文献
9.
ObjectiveTo analyze the effects of electrolysis, through a medium frequency current, associated to aerobic physical activity in the body composition of young women.MethodsThe study was composed of 34 sedentary women (24.35 ± 4.43 years, 71.30 ± 7.08 kg, 1.61 ± 0.06 m, 27.31 ± 1.67 kg/m2) which were evaluated for their anthropometric measures and body composition. The volunteers were randomly assigned to two group: Electrolyphysis plus Aerobic Exercise (gEEA): 17 volunteers were submitted to the application, for 60 min , of the Aussie current, followed by aerobic physical activity (77% of HRmax) on the trampoline for 40 min, through video-lessons of Jump; and Aerobic Exercise group (gEA): 17 volunteers performed only physical activity following the same parameters mentioned above. Each group performed its protocols twice weekly, for 5 weeks, totaling 10 sessions. For the data analysis, measures repeated ANOVA was performed to compare the means of the variables analyzed before and after the treatment protocols using the SPSS - 21.0 software, adopting a p ≤ 0.05.ResultsAlthough gEEA decreased suprailiac skinfold (p = 0.04), abdominal skinfold (p = 0.03) and circumference at umbilical scar (p = 0.02) in an intragroup analysis, these means differences in anthropometric measures were not important between-groups (p > 0.05). Furthermore, there were no effect of treatment on body composition (p > 0.05).ConclusionTo this studied condition, our results suggested that application of medium frequency electrolysis did not enhance the losses on anthropometric measures and body composition. 相似文献